XRAY vs KMTS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

XRAY

57.2
AI Score
VS
XRAY Wins

KMTS

45.6
AI Score

Investment Advisor Scores

XRAY

57score
Recommendation
HOLD

KMTS

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric XRAY KMTS Winner
Revenue 1.78B 66.49M XRAY
Net Income 27.00M -92.78M XRAY
Gross Margin 51.7% 49.9% XRAY
Net Margin 1.5% -139.5% XRAY
Operating Income 47.00M -95.40M XRAY
ROE 2.0% -32.2% XRAY
ROA 0.5% -24.5% XRAY
Total Assets 5.20B 379.34M XRAY
Cash 239.00M 291.32M KMTS
Debt/Equity 1.48 0.15 KMTS
Current Ratio 1.63 7.32 KMTS

Relative Price Performance (Last 90 Days)

XRAY 1M: -14.2% · 3M: +10.0% KMTS 1M: +25.1% · 3M: +25.2%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

KMTS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.0% over 20 days), RSI 57

RSI (14): 56.7 · Price: $26.99

Fundamentals Snapshot

Metric XRAY KMTS
Market Cap
Forward P/E 7.2 -12.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 0.5% 0.5%
Operating Margin 0.1% -1.4%
EPS -2.71 -2.38
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.